Six Internationally Distinguished Physicians
Join ESUN's Medical Editorial Advisory Board

An ESUN Feature

Bruce Shriver, PhD
Editor-in-Chief, ESUN

Over the past few years, the work of the Liddy Shriver Sarcoma Initiative has grown considerably. ESUN has become a robust open-access publication with a significant readership. Our Research Grants Program has now funded and co-funded more than $1 million in sarcoma research grants. As our initiatives grow, so does the need for members of our dual Medical Advisory and Medical Editorial Board. We are pleased to announce that six distinguished physicians have accepted appointments to our board starting in April 2010. They are:

Alessandro Gronchi, MD
Istituto Nazionale Tumori
Milan, Italy
Dr. Alessandro Gronchi
David Malkin, MD
The Hospital for Sick Children
Toronto, Canada
Dr. David Malkin
Piotr Rutkowski, MD, PhD
Sklodowska-Curie Memorial Cancer Center
and Institute of Oncology
Warsaw, Poland
Dr. Piotr Rutkowski
David Thomas, MD
Peter MacCallum Cancer Center
East Melbourne, Australia
Dr. David Thomas
Margaret von Mehren, MD
Fox Chase Cancer Center
Philadelphia, USA
Dr. Margaret von Mehren
Jeremy Whelan, MD
University College Hospital
London, United Kingdom
Dr. Jeremy Whelan


These physicians join a board that includes sarcoma surgeons, medical oncologists, clinicians, and researchers from eight different countries. They share a passion for helping those facing sarcoma and are dedicated to finding better treatments and a cure for sarcoma. Our board members provide invaluable service to the sarcoma community as they write and review articles for ESUN. They help us fund the best research possible by reviewing and recommending submissions to our Research Grants Program.

We are proud of the international nature of this board and are grateful for the unique backgrounds and experiences that these physicians bring to our efforts. They enhance our ability to draw submissions to ESUN and grant applications from physicians and researchers worldwide.

Our Medical Advisory and Editorial Board

Laurence Baker, DO, Southwest Oncology Group and SARC
Jean-Yves Blay, MD, PhD, Université Claude Bernard in Lyon, France
Murray Brennan, MD, Memorial Sloan-Kettering Cancer Center
Mark Gebhardt, MD, Harvard University, Beth Israel Deaconess Medical Center
Richard Gorlick, MD, The Children's Hospital at Montefiore
Alessandro Gronchi, MD, Istituto Nazionale Tumori in Milan, Italy
Mary Louise Keohan, MD, Memorial Sloan-Kettering Cancer Center
Crystal Mackall, MD, National Cancer Institute
David Malkin, MD, The Hospital for Sick Children in Toronto, Canada
Ole Steen Nielsen, MD, University of Aarhus in Aarhus, Denmark
Raphael Pollock, MD, PhD, University of Texas M. D. Anderson Cancer Center
R. Lor Randall, MD, University of Utah, Huntsman Cancer Institute
Piotr Rutkowski, MD, PhD, Sklodowska-Curie Memorial Cancer Center in Warsaw, Poland
David Thomas, MD, Peter MacCallum Cancer Centre in East Melbourne, Australia
Margaret von Mehren, MD, Fox Chase Cancer Center
Leonard Wexler, MD, Memorial Sloan-Kettering Cancer Center
Jeremy Whelan, MD, University College Hospital in London, United Kingdom


V7N2 ESUN Copyright © 2010 Liddy Shriver Sarcoma Initiative.